Cargando…
Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
Autor principal: | Guzik, Tomasz J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852616/ https://www.ncbi.nlm.nih.gov/pubmed/28525917 http://dx.doi.org/10.1093/cvr/cvx081 |
Ejemplares similares
-
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020) -
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19
por: Pessoa-Amorim, Guilherme, et al.
Publicado: (2021) -
ISCHEMIA: new questions from a landmark trial
por: Morrow, Andrew, et al.
Publicado: (2020) -
What to expect from drug targeting factor XI?
por: Nagy, Magdolna, et al.
Publicado: (2022) -
Highlights of American Heart Association Scientific Sessions 2020: a virtual experience
por: Adão, Rui, et al.
Publicado: (2021)